Skip to main content

Inmune Bio, Inc 10-K for FY2022

Inmune Bio, Inc. (INMB)

10-K 2023-03-02 For: 2022-12-31
View Original
Added on April 07, 2026

About this 10-K

Inmune Bio, Inc filed this 10-K on March 2, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$374K
up 106.6% from $181K a year earlier
Net loss
$27.3M
compared with a net loss of $30.34M a year earlier
Diluted EPS
-$1.52
compared with -$1.88 a year earlier